about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index



James S. Ferriss, MD


Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences

Associate Residency Program Director, Obstetrics, Gynecology and Reproductive Sciences

Director, Clinical Simulation, Obstetrics, Gynecology and Reproductive Sciences


Telephone:  215-707-3008

Email: james.ferriss@tuhs.temple.edu



Department of Obstetrics, Gynecology and Reproductive Sciences


Educational Background:


Undergraduate degree, Louisiana State University, Baton Rouge, LA, 1999


MD, Louisiana State University, New Orleans, LA, 2003


Internship and Residency, University of Texas Southwestern/ Parkland Hospital, Dallas, TX, 2007


Fellowship, University of Virginia, Charlottesville, VA, 2010


Return to top



clinical Interests:

  • Cancers of the ovary, uterus, cervix, vulva
  • Chemotherapy
  • Clinical research
  • Robotic surgery
  • Laparoscopic surgery

Return to top



board certifications:

  • Board certified, Obstetrics and Gynecology
  • Board certified, Gynecologic Oncology

Return to top



professional affiliations:

  • American College of Obstetricians and Gynecologists
  • Society of Gynecologic Oncologists

Return to top



research interests:


  • Cellular origins of ovarian cancer
  • Immunotherapy for dysplasia, cervical and vulvar cancers
  • Clinical trials

Return to top





Ferriss JS, King E, Modesitt SC.  "Borderline Epithelial Ovarian Tumors, Sex Cord-Stromal Tumors and Germ Cell Tumors of the Ovary" in Early Diagnosis and Treatment of Cancer Series: Ovarian Cancer. Bristow R, Armstrong D., eds. Elsevier, 2009.


Return to top




Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

26216729. Ferriss JS, Java JJ, Bookman MA, Fleming GF, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente MP, Burger RA, Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study. Gynecol Oncol 139:1(17-22)2015 Oct

25431594. Diaz J, Yu D, Micaily B, Ferriss JS, Hernandez E, Radiation therapy with concurrent chemotherapy for locally advanced cervical carcinoma: outcome analysis with emphasis on the impact of treatment duration on outcome. Obstet Gynecol Int 2014:(214351)2014

22503523. Kemmerer E, Hernandez E, Ferriss JS, Valakh V, Miyamoto C, Li S, Micaily B, Use of image-guided stereotactic body radiation therapy in lieu of intracavitary brachytherapy for the treatment of inoperable endometrial neoplasia. Int J Radiat Oncol Biol Phys 85:1(129-35)2013 Jan 1

22426409. Ferriss JS, Ring K, King ER, Courtney-Brooks M, Duska LR, Taylor PT, Does significant medical comorbidity negate the benefit of up-front cytoreduction in advanced ovarian cancer? Int J Gynecol Cancer 22:5(762-9)2012 Jun

22348014. Ferriss JS, Kim Y, Duska L, Birrer M, Levine DA, Moskaluk C, Theodorescu D, Lee JK, Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance. PLoS One 7:2(e30550)2012

22028616. Jazaeri AA, Bryant JL, Park H, Li H, Dahiya N, Stoler MH, Ferriss JS, Dutta A, Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Neoplasia 13:10(899-911)2011 Oct

21546746. Saeed-Vafa D, Myers E, Huang Y, Ferriss JS, Manucha V, Localized cavernous hemangioma of the uterus involving adenomyotic foci. J Cancer Res Ther 7:1(69-71)2011 Jan-Mar

20966686. Ferriss JS, Brix W, Tambouret R, DeSimone CP, Stoler M, Modesitt SC, Cervical stromal invasion predicting survival in endometrial cancer. Obstet Gynecol 116:5(1035-41)2010 Nov

20462630. Jazaeri AA, Ferriss JS, Bryant JL, Dalton MS, Dutta A, Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer. Gynecol Oncol 118:2(189-95)2010 Aug 1

20130512. Ferriss JS, Atkins KA, Lachance JA, Modesitt SC, Jazaeri AA, Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series. Int J Gynecol Cancer 20:1(120-5)2010 Jan

19922988. Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N, When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Gynecol Oncol 116:3(374-7)2010 Mar

19844714. Greene DP, Ferriss JS, Jazaeri AA, Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report. Cancer Chemother Pharmacol 66:2(265-7)2010 Jul

19476897. McCawley GM, Ferriss JS, Geffel D, Northup CJ, Modesitt SC, Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg 208:6(1093-8)2009 Jun

Return to top